公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
KTD104	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠）	DDX41 facilitates PD-L1-mediated immune escape in OSCC via the phase separation and activation STING pathway	9.900	NPJ Precision Oncology
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	Serine is an endogenous brake on NEDD4-driven SLC7A11 degradation to suppress oxidative stress in sterile inflammation	/	papers.ssrn.com
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	SIRT3 deficiency drives alveolar epithelial mitochondrial dysfunction in bronchopulmonary dysplasia via PDHA1 hyperacetylation	4.500	iScience
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	Nlrp12-driven PANoptosis exacerbates liver injury in ConA-induced autoimmune hepatitis	4	Genes &Immunity
KTD105	通用型免疫（共）沉淀（IP/Co-IP）工具箱（琼脂糖）	Serine Stabilizes SLC7A11 and Enhances Cystine Influx to Protect Against Acute Pancreatitis	/	bioRxiv (预印本)
KTD106	通用型免疫印迹（WB）工具箱	Constructing a prognostic risk model for Alzheimer's disease based on ferroptosis	4	Frontiers in Aging Neuroscience
KTD106	通用型免疫印迹（WB）工具箱	Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2	7	Journal of Hospital Infection
KTI1010	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠/抗小鼠）	Co-localization of TAZ and H2A. Z up-regulates IL-6 expression in alveolar epithelial cells to polarize M2 cells to alleviate hypoxia-induced lung injury.	9	Genes & Diseases
KTI1010	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠/抗小鼠）	Targeted inhibition of NEK7 preventing sepsis-induced cardiomyopathy by inhibiting NLRP3 inflammasome.	5	International Immunopharmacology
KTI1010	通用型免疫（共）沉淀（IP/Co-IP）工具箱（磁珠/抗小鼠）	Restoration of SIRT3 Expression in Aged Mice Alleviates UUO‐Induced Renal Fibrosis by Reducing GSK‐3β Hyperacetylation	14	International Journal of Biological Macromolecules

首页上一页 186 187 188 189 190 191 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部